Trial
NCT04581109
Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Montpellier
Collaborators
—
Condition
Prostate Cancer
Intervention
Blood sample
Why stopped
Flaw in the analytical technique
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-22